Pharmasaga Co. Ltd. (TPEX:7878)
Taiwan · Delayed Price · Currency is TWD 139.50
-6.00 (-4.12%)
At close: Sep 2, 2026
Pharmasaga Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 217.02 | 164.7 | 21.87 | 154.64 | 36.73 |
Short-Term Investments | 282.35 | 365.35 | 156.86 | - | - |
Cash & Short-Term Investments | 499.37 | 530.05 | 178.73 | 154.64 | 36.73 |
Cash Growth | -10.99% | 196.57% | 15.58% | 320.99% | - |
Other Receivables | 1.58 | - | 0.02 | 0.06 | - |
Receivables | 1.58 | - | 0.02 | 0.06 | - |
Prepaid Expenses | 8.74 | 7.73 | 3.62 | 0.95 | 0.07 |
Other Current Assets | 16.72 | 0.02 | 0.22 | - | - |
Total Current Assets | 526.42 | 537.8 | 182.59 | 155.65 | 36.81 |
Property, Plant & Equipment | 9.12 | 8.59 | 0.27 | - | - |
Other Intangible Assets | 64.76 | 68.33 | 75.47 | 82.34 | 89.39 |
Other Long-Term Assets | 0.35 | 17.17 | 16.82 | 0.09 | 0.03 |
Total Assets | 600.64 | 631.89 | 275.15 | 238.08 | 126.23 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accrued Expenses | 10.57 | 24.06 | 13.03 | 6.57 | 0.19 |
Current Portion of Leases | 1.69 | 1.45 | 0.26 | - | - |
Other Current Liabilities | 0.42 | 0.29 | 0.73 | 0.38 | 0.01 |
Total Current Liabilities | 12.68 | 25.8 | 14.02 | 6.95 | 0.19 |
Long-Term Leases | 4.79 | 5.55 | - | - | - |
Total Liabilities | 17.47 | 31.35 | 14.02 | 6.95 | 0.19 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 535.37 | 535.37 | 282.01 | 126.47 | 126.47 |
Additional Paid-In Capital | 75.58 | 146.16 | 60 | 13.33 | 13.33 |
Retained Earnings | -42.67 | -80.99 | -80.88 | -41.19 | -13.76 |
Comprehensive Income & Other | 14.9 | - | - | 132.52 | - |
Shareholders' Equity | 583.17 | 600.54 | 261.13 | 231.13 | 126.04 |
Total Liabilities & Equity | 600.64 | 631.89 | 275.15 | 238.08 | 126.23 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 6.48 | 7 | 0.26 | - | - |
Net Cash (Debt) | 492.9 | 523.05 | 178.47 | 154.64 | 36.73 |
Net Cash Growth | -11.60% | 193.08% | 15.41% | 320.99% | - |
Net Cash Per Share | 9.20 | 10.40 | 4.78 | 7.12 | 1.90 |
Filing Date Shares Outstanding | 53.54 | 53.54 | 28.2 | 12.65 | 19.29 |
Total Common Shares Outstanding | 53.54 | 53.54 | 28.2 | 12.65 | 19.29 |
Working Capital | 513.73 | 512 | 168.57 | 148.7 | 36.62 |
Book Value Per Share | 10.89 | 11.22 | 9.26 | 18.28 | 6.53 |
Tangible Book Value | 518.41 | 532.21 | 185.66 | 148.79 | 36.65 |
Tangible Book Value Per Share | 9.68 | 9.94 | 6.58 | 11.77 | 1.90 |
Machinery | 0.6 | 0.3 | - | - | - |
Leasehold Improvements | 3.09 | 1.66 | - | - | - |